A better understanding of the disease biology is needed to develop new treatments for lymphoma patients. This collaborative project was set up to support CALYM teams research activities:

  • development of in vivo and in vitro models
  • study of the role of the microenvironment
  • study of molecular heterogeneity
  • identification of peripheral blood and tissue biomarkers specific to each lymphoma subtype